Patent details

EP2481402 Title: Nanoparticle comprising rapamycin and albumin as anticancer agent

Basic Information

Publication number:
EP2481402
PCT Application Number:
Type:
European Patent Granted for LU
Legal Status:
In force
Application number:
EP121524557
PCT Publication Number:
First applicant's nationality:
Translation Language:
EPO Publication Language:
English
English Title of Invention:
Nanoparticle comprising rapamycin and albumin as anticancer agent
French Title of Invention:
Nanoparticule comportant du rapamycine et albumine en tant qu'agent anti-cancer
German Title of Invention:
Nanopartikel mit Rapamycin und Albumin als Antikrebsmittel
SPC Number:

Dates

Filing date:
07/03/2008
Grant date:
09/05/2018
EP Publication Date:
01/08/2012
PCT Publication Date:
Claims Translation Received Date:
Translations Received Date (B1 EP Publication):
Translations Received Date (B2 EP Publication):
Translations Received Date (B3 EP Publication):
Publication date:
09/05/2018
EP B1 Publication Date:
09/05/2018
EP B2 Publication Date:
EP B3 Publication Date:
Lapsed date:
Expiration date:
07/03/2028
Renunciation date:
Revocation date:
Annulment date:

Owner

From:
02/05/2018
 
 

Name:
Abraxis BioScience, LLC
Address:
86 Morris Avenue, Summit, NJ 07901, United States (US)

Agent

Name:
VALIPAT
From:
12/07/2018
Address:
Uitbreidingstraat 72-5, 2600, Antwerp, Belgium (BE)
To:

Inventor

1

Name:
Trieu, Vuong
Address:
United States (US)

2

Name:
Desai, Neil, P.
Address:
United States (US)

3

Name:
Soon-Shiong, Patrick
Address:
United States (US)

Priority

1

Priority Number:
905735 P
Priority Date:
07/03/2007
Priority Country:
United States (US)

2

Priority Number:
905669 P
Priority Date:
07/03/2007
Priority Country:
United States (US)

3

Priority Number:
905767 P
Priority Date:
07/03/2007
Priority Country:
United States (US)

4

Priority Number:
905734 P
Priority Date:
07/03/2007
Priority Country:
United States (US)

5

Priority Number:
905663 P
Priority Date:
07/03/2007
Priority Country:
United States (US)

6

Priority Number:
905672 P
Priority Date:
07/03/2007
Priority Country:
United States (US)

7

Priority Number:
905750 P
Priority Date:
07/03/2007
Priority Country:
United States (US)

8

Priority Number:
905662 P
Priority Date:
07/03/2007
Priority Country:
United States (US)

9

Priority Number:
905787 P
Priority Date:
07/03/2007
Priority Country:
United States (US)

10

Priority Number:
923248 P
Priority Date:
13/04/2007
Priority Country:
United States (US)

11

Priority Number:
923456 P
Priority Date:
13/04/2007
Priority Country:
United States (US)

Classification

IPC classification:
A61K 9/19; A61K 9/51; A61K 31/436; A61K 31/517; A61K 31/685; A61K 31/704; A61P 35/00;

Publication

European Patent Bulletin

Issue number:
201819
Publication date:
09/05/2018
Description:
Grant (B1)

Deed

Power of attorney

Change Kind/ Decision Type:
Assignment
Deed Number:
RC20180000240A
Date Registered:
12/07/2018
Licence Effective Date:
Licence Expiration Date:
Scope of Licence:
Deed Filer:
VALIPAT
Journal Edition Number:
Text:
Country Code:
Updated Licence Number:
Terminated Licence Number:

Removed Pledgee

Name:
Address:

Annual Fees

Annual Fee Due Date:
31/03/2026
Annual Fee Number:
19
Annual Fee Amount:
281 Euro
Expected Payer:
Last Annual Fee Payment Date:
27/02/2025
Last Annual Fee Paid Number:
18
Last Annual Fee Paid Amount:
262 Euro
Payer:
CPA GLOBAL THE IP PLATFORM
Filing date Document type Number of pages
16/07/2018 Outgoing Correspondence 1
12/07/2018 Request For Change 1